Complete Blood Morphology: Breaking the Relationship Between Sample Volume and Morphology Throughput

Every stage of the hematology workflow has been automated and standardized – except one. Peripheral blood smear review still depends on routine human intervention for every case, creating a structural bottleneck that scales only with headcount. With rising diagnostic volumes, increasing case complexity, and a shrinking workforce, that model is reaching its limit.

This white paper examines why current digital morphology platforms have not solved the throughput constraint, and how autovalidated blood smear analysis can decouple sample volume from review capacity – without removing expert oversight where it matters most.

In this white paper, you will learn:

• Why blood smear review remains the primary throughput constraint in hematology operations
• How rising demand and workforce contraction are creating a hard capacity ceiling
• Why first-generation digital morphology improved efficiency but did not enable autovalidation
• How Complete Blood Morphology introduces autonomous analysis for routine cases, with expert review preserved for complex findings
• Early performance observations from a dataset of approximately 2,500 peripheral blood smear slides

*Scopio’s Complete Blood Morphology Analyzer (CBM) is in development and not yet available for in vitro diagnostic use.